Use of gadopentetate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty and stent placement
- 1 February 1998
- journal article
- case report
- Published by Elsevier in Kidney International
- Vol. 53 (2) , 503-507
- https://doi.org/10.1046/j.1523-1755.1998.00764.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures.Radiology, 1996
- Nephrotoxicity of high‐dose gadolinium compared with iodinated contrastJournal of Magnetic Resonance Imaging, 1996
- Safety of gadodiamide injection in two different age groupsJournal of Magnetic Resonance Imaging, 1996
- Gadopentetate dimeglumine as an alternative contrast material for use in angiography.American Journal of Roentgenology, 1993
- Renal Tolerance of Gadolinium-DTPA/Dimeglumine in Patients with Chronic Renal FailureInvestigative Radiology, 1992
- Safety and Tolerance after Intravenous Administration of 0.3 mmol/kg Gd-DTPA: Results of a Randomized, Controlled Clinical TrialInvestigative Radiology, 1991
- Nephrotoxicity of contrast mediaKidney International, 1989
- New and old contrast agents: Physiology and nephrotoxicityUrologic Radiology, 1988
- Renovascular operations in patients with chronic renal insufficiency: Do the benefits justify the risks?Journal of Vascular Surgery, 1987
- Radiocontrast-Induced Acute Renal FailureMedicine, 1979